Taken together, natural anti-HER2 IgG levels are likely to impact the tumorigenesis of OSCC based on the present findings that anti-HER2 IgG-abundant plasma could significantly inhibit the proliferation and invasion of OSCC cells, and induce the apoptosis of these cancer cells. This evidence concerns the gene ERBB2 and cancer.